Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aescin and MPFF for Acute Internal Hemorrhoids
NCT06748014Phase 1Enrolling by invitation
- Sponsor
- Chiang Mai University
- Start
- Dec 2024
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of escin in internal hemorrhoids, sponsored by Chiang Mai University. Primary endpoint: Recurrence of hemorrhoid at 6 months. Started Dec 2024; status: enrolling by invitation.
02
Drugs
escin
03
Conditions
internal hemorrhoids
Beyond the preview
Go deeper on NCT06748014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06748014.